Innate lymphoid cells are pivotal actors in allergic, inflammatory and autoimmune diseases

References

• Spits H, Cupedo T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol 2012;30:647-75
   PubMed Web of Science ®Google Scholar
• Boyd A, Ribeiro JM, Nutman TB. Human CD117 (cKit)+ innate lymphoid cells have a discrete transcriptional profile at homeostasis and are expanded during filarial infection. PLoS One 2014;9(9):e108649
   Google Scholar
• Halim TY, Steer CA, Matha L, et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 2014;40(3):425-35
   PubMed Web of Science ®Google Scholar
• Diefenbach A. Profiling the diversity of innate lymphoid cells. Nat Immunol 2015;16(3):222-4
   Google Scholar
• Bellora F, Castriconi R, Dondero A, et al. Human NK cells and NK receptors. Immunol Lett 2014;161(2):168-73
   PubMed Web of Science ®Google Scholar
• Renner P, Rovira J, Klein C, et al. KLRG1 natural killer cells protect against pulmonary metastatic disease by immunosurveillance. Oncoimmunology 2014;3:e28328
   Google Scholar
• Diefenbach A, Colonna M, Koyasu S. Development, differentiation, and diversity of innate lymphoid cells. Immunity 2014;41(3):354-65
   PubMed Web of Science ®Google Scholar
• Daussy C, Faure F, Mayol K, et al. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J Exp Med 2014;211(3):563-77
   Google Scholar
• Gordon SM, Chaix J, Rupp LJ, et al. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 2012;36(1):55-67
   PubMed Web of Science ®Google Scholar
• Spits H, Artis D, Colonna M, et al. Innate lymphoid cells–a proposal for uniform nomenclature. Nat Rev Immunol 2013;13(2):145-9
   PubMed Web of Science ®Google Scholar
• Roediger B, Kyle R, Yip KH, et al. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat Immunol 2013;14(6):564-73
   PubMed Web of Science ®Google Scholar
• Kim BS, Siracusa MC, Saenz SA, et al. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med 2013;5(170):170ra116
   Web of Science ®Google Scholar
• Vosshenrich CA, Garcia-Ojeda ME, Samson-Villeger SI, et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat Immunol 2006;7(11):1217-24
   PubMed Web of Science ®Google Scholar
• Lee MW, Odegaard JI, Mukundan L, et al. Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 2015;160(1-2):74-87
   Google Scholar
• Vacca P, Montaldo E, Croxatto D, et al. Identification of diverse innate lymphoid cells in human decidua. Mucosal Immunol 2015;8(2):254-64
   Google Scholar
• Satoh-Takayama N, Lesjean-Pottier S, Vieira P, et al. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. J Exp Med 2010;207(2):273-80
   Google Scholar
• Klose CS, Flach M, Mohle L, et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 2014;157(2):340-56
   PubMed Web of Science ®Google Scholar
• Mjosberg JM, Trifari S, Crellin NK, et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011;12(11):1055-62
   PubMed Web of Science ®Google Scholar
• Cayrol C, Girard JP. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol 2014;31C:31-7
   Google Scholar
• Aryan Z, Compalati E, Canonica GW, et al. Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications. Expert Rev Vaccines 2013;12(6):639-59
   PubMed Web of Science ®Google Scholar
• Yang Q, Saenz SA, Zlotoff DA, et al. Cutting edge: Natural helper cells derive from lymphoid progenitors. J Immunol 2011;187(11):5505-9
   Google Scholar
• Chang YJ, Kim HY, Albacker LA, et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 2011;12(7):631-8
   PubMed Web of Science ®Google Scholar
• Enomoto Y, Orihara K, Takamasu T, et al. Tissue remodeling induced by hypersecreted epidermal growth factor and amphiregulin in the airway after an acute asthma attack. J Allergy Clin Immunol 2009;124(5):913-20; e911-917
   Google Scholar
• Monticelli LA, Sonnenberg GF, Abt MC, et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011;12(11):1045-54
   PubMed Web of Science ®Google Scholar
• Chu DK, Llop-Guevara A, Walker TD, et al. IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization. J Allergy Clin Immunol 2013;131(1):187-200; e181-188
   PubMed Web of Science ®Google Scholar
• Ho J, Bailey M, Zaunders J, et al. Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia. Clin Exp Allergy 2015;45(2):394-403
   PubMed Web of Science ®Google Scholar
• Miljkovic D, Bassiouni A, Cooksley C, et al. Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis. Allergy 2014;69(9):1154-61
   PubMed Web of Science ®Google Scholar
• Shaw JL, Fakhri S, Citardi MJ, et al. IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps. Am J Respir Crit Care Med 2013;188(4):432-9
   PubMed Web of Science ®Google Scholar
• Nabavi M, Arshi S, Bahrami A, et al. Increased level of interleukin-13, but not interleukin-4 and interferon-gamma in chronic rhinosinusitis with nasal polyps. Allergol Immunopathol (Madr) 2014;42(5):465-71
   PubMed Web of Science ®Google Scholar
• Nabavi M, Esmaeilzadeh H, Arshi S, et al. Aspirin hypersensitivity in patients with chronic rhinosinusitis and nasal polyposis: frequency and contributing factors. Am J Rhinol Allergy 2014;28(3):239-43
   PubMed Web of Science ®Google Scholar
• Juncadella IJ, Kadl A, Sharma AK, et al. Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation. Nature 2013;493(7433):547-51
   PubMed Web of Science ®Google Scholar
• Barnig C, Cernadas M, Dutile S, et al. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med 2013;5(174):174ra126
   Google Scholar
• Kim HY, Lee HJ, Chang YJ, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med 2014;20(1):54-61
   PubMed Web of Science ®Google Scholar
• Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011;242(1):233-46
   PubMed Web of Science ®Google Scholar
• Poninska J, Samolinski B, Tomaszewska A, et al. Filaggrin gene defects are independent risk factors for atopic asthma in a Polish population: a study in ECAP cohort. PLoS One 2011;6(2):e16933
   Google Scholar
• Kinoshita H, Takai T, Le TA, et al. Cytokine milieu modulates release of thymic stromal lymphopoietin from human keratinocytes stimulated with double-stranded RNA. J Allergy Clin Immunol 2009;123(1):179-86
   Google Scholar
• Marodi L, Casanova JL. Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments. J Allergy Clin Immunol 2010;126(5):910-17
   Google Scholar
• Salimi M, Barlow JL, Saunders SP, et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 2013;210(13):2939-50
   PubMed Web of Science ®Google Scholar
• Morris JC, Tan AR, Olencki TE, et al. Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFbeta) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma. PLoS One 2014;9(3):e90353
   PubMed Web of Science ®Google Scholar
• Oliphant CJ, Hwang YY, Walker JA, et al. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 2014;41(2):283-95
   PubMed Web of Science ®Google Scholar
• Leung DY, Gao PS, Grigoryev DN, et al. Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-gamma response. J Allergy Clin Immunol 2011;127(4):965-73; e961-965
   Google Scholar
• Gao PS, Leung DY, Rafaels NM, et al. Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum. J Invest Dermatol 2012;132(3 Pt 1):650-7
   Google Scholar
• Mathias RA, Weinberg A, Boguniewicz M, et al. Atopic dermatitis complicated by eczema herpeticum is associated with HLA B7 and reduced interferon-gamma-producing CD8+ T cells. Br J Dermatol 2013;169(3):700-3
   Google Scholar
• Palm O, Moum B, Ongre A, et al. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). J Rheumatol 2002;29(3):511-15
   PubMed Web of Science ®Google Scholar
• Najarian DJ, Gottlieb AB. Connections between psoriasis and Crohn’s disease. J Am Acad Dermatol 2003;48(6):805-21; quiz 822-804
   PubMed Web of Science ®Google Scholar
• Bernink JH, Peters CP, Munneke M, et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 2013;14(3):221-9
   PubMed Web of Science ®Google Scholar
• Danese S, Panes J. Development of drugs to target interactions between leukocytes and endothelial cells and treatment algorithms for inflammatory bowel diseases. Gastroenterology 2014;147(5):981-9
   PubMed Web of Science ®Google Scholar
• Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 2011;12(5):383-90
   PubMed Web of Science ®Google Scholar
• Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010;10(7):479-89
   PubMed Web of Science ®Google Scholar
• Buonocore S, Ahern PP. Uhlig HH, et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010;464(7293):1371-5
   PubMed Web of Science ®Google Scholar
• Klose CS, Kiss EA, Schwierzeck V, et al. A T-bet gradient controls the fate and function of CCR6-RORgammat+ innate lymphoid cells. Nature 2013;494(7436):261-5
   PubMed Web of Science ®Google Scholar
• Takatori H, Kanno Y, Watford WT, et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 2009;206(1):35-41
   PubMed Web of Science ®Google Scholar
• Hue S, Ahern P, Buonocore S, et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 2006;203(11):2473-83
   PubMed Web of Science ®Google Scholar
• Eken A, Singh AK, Treuting PM, et al. IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism. Mucosal Immunol 2014;7(1):143-54
   Web of Science ®Google Scholar
• Yao Z, Spriggs MK, Derry JM, et al. Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine 1997;9(11):794-800
   PubMed Web of Science ®Google Scholar
• O’Connor WJr, Kamanaka M, Booth CJ, et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 2009;10(6):603-9
   PubMed Web of Science ®Google Scholar
• Hueber W, Sands BE, Lewitzky S, et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn’s disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 2012;61(12):1693-700
   PubMed Web of Science ®Google Scholar
• Langley RG, Elewski BE, Lebwohl M, et al. Secukinumab in plaque psoriasis–results of two phase 3 trials. N Engl J Med 2014;371(4):326-38
   PubMed Web of Science ®Google Scholar
• Song L, Zhou R, Huang S, et al. High intestinal and systemic levels of interleukin-23/T-helper 17 pathway in Chinese patients with inflammatory bowel disease. Mediators Inflamm 2013;2013; 425915
   Google Scholar
• Jiang W, Su J, Zhang X, et al. Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease. Inflamm Res 2014;63(11):943-50
   PubMed Web of Science ®Google Scholar
• Fujino S, Andoh A, Bamba S, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003;52(1):65-70
   PubMed Web of Science ®Google Scholar
• Dyring-Andersen B, Geisler C, Agerbeck C, et al. Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin. Br J Dermatol 2014;170(3):609-16
   Google Scholar
• Eken A, Singh AK, Oukka M. Interleukin 23 in Crohn’s disease. Inflamm Bowel Dis 2014;20(3):587-95
   PubMed Web of Science ®Google Scholar
• Martinez NE, Sato F, Kawai E, et al. Th17-biased RORgammat transgenic mice become susceptible to a viral model for multiple sclerosis. Brain Behav Immun 2015;43:86-97
   Google Scholar
• Cella M, Fuchs A, Vermi W, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009;457(7230):722-5
   PubMed Web of Science ®Google Scholar
• Geremia A, Arancibia-Carcamo CV, Fleming MP, et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 2011;208(6):1127-33
   PubMed Web of Science ®Google Scholar
• Claes IJ, Vargas Garcia CE, Lebeer S. Novel opportunities for the exploitation of host-microbiome interactions in the intestine. Curr Opin Biotechnol 2014;32C:28-34
   Google Scholar
• Shouval DS, Biswas A, Goettel JA, et al. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. Immunity 2014;40(5):706-19
   PubMed Web of Science ®Google Scholar
• Lin L, Ma C, Wei B, et al. Human NK cells licensed by killer Ig receptor genes have an altered cytokine program that modifies CD4+ T cell function. J Immunol 2014;193(2):940-9
   PubMed Web of Science ®Google Scholar
• Lopez-Sagaseta J, Dulberger CL, McFedries A, et al. MAIT recognition of a stimulatory bacterial antigen bound to MR1. J Immunol 2013;191(10):5268-77
   Google Scholar
• Serriari NE, Eoche M, Lamotte L, et al. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin Exp Immunol 2014;176(2):266-74
   PubMed Web of Science ®Google Scholar
• Massot B, Michel ML, Diem S, et al. TLR-induced cytokines promote effective proinflammatory natural Th17 cell responses. J Immunol 2014;192(12):5635-42
   PubMed Web of Science ®Google Scholar
• Hedayat M, Takeda K, Rezaei N. Prophylactic and therapeutic implications of toll-like receptor ligands. Med Res Rev 2012;32(2):294-325
   PubMed Web of Science ®Google Scholar
• Pantelyushin S, Haak S, Ingold B, et al. Rorgammat+ innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice. J Clin Invest 2012;122(6):2252-6
   PubMed Web of Science ®Google Scholar
• Huh JR, Leung MW, Huang P, et al. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgammat activity. Nature 2011;472(7344):486-90
   PubMed Web of Science ®Google Scholar
• Keijsers RR, Hendriks AG, van Erp PE, et al. In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing RORgammat and IL-17. J Invest Dermatol 2014;134(5):1276-84
   Google Scholar
• Villanova F, Flutter B, Tosi I, et al. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J Invest Dermatol 2014;134(4):984-91
   PubMed Web of Science ®Google Scholar
• Teunissen MB, Munneke JM, Bernink JH, et al. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients. J Invest Dermatol 2014;134(9):2351-60
   PubMed Web of Science ®Google Scholar
• Nelson GW, Martin MP, Gladman D, et al. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 2004;173(7):4273-6
   PubMed Web of Science ®Google Scholar
• Tsoi LC, Spain SL, Knight J, et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 2012;44(12):1341-8
   PubMed Web of Science ®Google Scholar
• Tang F, Sally B, Ciszewski C, et al. Interleukin 15 primes natural killer cells to kill via NKG2D and cPLA2 and this pathway is active in psoriatic arthritis. PLoS One 2013;8(9):e76292
   PubMed Web of Science ®Google Scholar
• Maizels RM, Withers DR. MHC-II: a mutual support system for ILCs and T cells? Immunity 2014;41(2):174-6
   Google Scholar
• Hepworth MR, Monticelli LA, Fung TC, et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 2013;498(7452):113-17
   PubMed Web of Science ®Google Scholar
• Ortega HG, Liu MC, Pavord ID, et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med 2014;371(13):1198-207
   PubMed Web of Science ®Google Scholar
• Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med 2011;365(12):1088-98
   PubMed Web of Science ®Google Scholar
• Ribas A, Kefford R, Marshall MA, et al. Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma. J Clin Oncol 2013;31(5):616-22
   PubMed Web of Science ®Google Scholar
• Castro JE, Choi MY, Carvajal T, et al. Ofatumumab and high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia. Blood Cancer J 2014;6:e258
   Google Scholar
• Quackenbush RC, Horner TJ, Williams VC, et al. Patients with relapsed follicular lymphoma treated with rituximab versus tositumomab and iodine I-131 tositumomab. Leuk Lymphoma 2015;56(3):779-81
   PubMed Web of Science ®Google Scholar
• Persky DO, Miller TP, Unger JM, et al. Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high risk limited stage aggressive B-cell lymphoma: SWOG S0313. Blood 2015;125(2):236-41
   PubMed Web of Science ®Google Scholar
• Lopez MN, Pereda C, Segal G, et al. Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells. J Clin Oncol 2009;27(6):945-52
   PubMed Web of Science ®Google Scholar
• Icheva V, Kayser S, Wolff D, et al. Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. J Clin Oncol 2013;31(1):39-48
   PubMed Web of Science ®Google Scholar
• Mackensen A, Meidenbauer N, Vogl S, et al. Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma. J Clin Oncol 2006;24(31):5060-9
   PubMed Web of Science ®Google Scholar
• Chang AE, Li Q, Jiang G, et al. Phase II trial of autologous tumor vaccination, anti-CD3-activated vaccine-primed lymphocytes, and interleukin-2 in stage IV renal cell cancer. J Clin Oncol 2003;21(5):884-90
   PubMed Web of Science ®Google Scholar
• Aryan Z, Holgate ST, Radzioch D, et al. A new era of targeting the ancient gatekeepers of the immune system: toll-like agonists in the treatment of allergic rhinitis and asthma. Int Arch Allergy Immunol 2014;164(1):46-63
   PubMed Web of Science ®Google Scholar
• Eberl G, Marmon S, Sunshine M-J, et al. An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells. Nat immunol 2004;5(1):64-73
   PubMed Web of Science ®Google Scholar
• Cupedo T, Crellin NK, Papazian N, et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 2009;10(1):66-74
   PubMed Web of Science ®Google Scholar